Purchases and Sales Made in Q4 2024 in Bio Line Rx Ltd. (BLRX)
This table provides information about the institutional ownership of Bio Line Rx Ltd. (BLRX) during Q4 2024. The information is specifically focused on institutions that hold shares of BioLineRx Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 08, 2025
Q4 2024
|
Watts Gwilliam & Co., LLC
Gilbert, AZ |
BUY
|
- |
34KNew |
$6.8K - $20.4K
|
34K
$113K
|
|
Jan 21, 2025
Q4 2024
|
Gradient Investments LLC
|
BUY
|
- |
11.4K+ 38.0% |
$2.28K - $6.84K
|
41.4K
$138K
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
10.4K+ 31.74% |
$2.07K - $6.21K
|
43K
$143K
|
|
Jan 06, 2025
Q4 2024
|
Neville Rodie & Shaw Inc
|
BUY
|
- |
10KNew |
$2K - $6K
|
10K
$33.3K
|
|
Jan 29, 2025
Q4 2024
|
Hibernia Wealth Partners, LLC
Baton Rouge, LA |
BUY
|
- |
10KNew |
$2K - $6K
|
10K
$33.3K
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
3.1KNew |
$621 - $1.86K
|
3.1K
$10.3K
|
|
Jan 21, 2025
Q4 2024
|
Geneos Wealth Management Inc.
|
BUY
|
- |
300+ 6.67% |
$60 - $180
|
4.8K
$16K
|
|
Jan 07, 2025
Q4 2024
|
Weaver Consulting Group
|
SELL
|
- |
-18.7K- 63.02% |
$3.75K - $11.2K
|
11K
$36.6K
|
|
Jan 29, 2025
Q4 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-31.1K- 15.73% |
$6.21K - $18.6K
|
166K
$554K
|